Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same
CA 2117953 C · Owner: Ono Pharmaceutical Co. Ltd. · Inventors: Honjo, Tasuku; Tada, Hideaki; Shirozu, Michio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The polypeptides of the present invention are produced and secreted in pro-B cells and may be used for diseases relating to undergrown or abnormal proliferation of hematopoietic cells neuronal enhancement or depression, immunological enhancement and depression for example, inflammatory diseases (rheumatoid arthritis ulcerative colitis, etc.), hematopoietic stemcytopenia after bone marrow transplantation leukocytopenia, thrombocytopenia, B lymphopenia and T lymphopenia after chemotherapy anemia, infectious diseases, cancer, leukocytosis AIDS, neurodegenerative diseases (Alzheimer multiple sclerosis, etc.), prevention or treatment of neuronal injury prevention or treatment of disorder of bone …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 12, 1994 and granted December 11, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 12, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 12, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.